Replies to post #784503 on NorthWest Biotherapeutics Inc (NWBO)

[jesster64]

My mother (88) told me a few years ago I'm always chasing windmills and every stock I advised them on was a "bummer". I'm hoping to show up at their house on halloween in my don quixote costume. I allready know how to say I told you so in German. I might even bring them a few cases of good beer. Question is at what profit margin will it be safe to buy another pinball machine so my wife can't object? It feels good to imagine again what to do with money. I fully expect another SP attack tomorrow or tuesday, but right now this feels good. Keps those PR's coming. I will now change my vote to yes for bonuses.

[apmarshall]

I too have scratched my head over the Advent deal. It does seem like a gift from Linda Powers to NWBO.

I agree with others who have posted that the deal vastly increases the number of employees in the company (historically NWBO has had 10-15 employees and Advent last I read has 80). Also, it will likely represent the first major step in a changing of the guard at NWBO with an infusion of younger talent who will lead the company forward on the manufacturing side. I do think that in the coming weeks we'll see announcements of major share/option/warrant awards to the Advent people.

I'm not sophisticated enough to understand the full logic for keeping Advent separate from NWBO but clearly Ms. Powers has proven the naysayers wrong about her motivations. In addition, I think it's quite possible this transaction will be looked upon as the benchmark moment when Ms. Powers turned the tables on the shorts. They likely wouldn't have anticipated such an "altruistic" move which in one fell swoop removes the major objection institutions and professional investors had to considering NWBO. Now, when they look at the company, they'll see only an extremely favorable risk/reward equation. Today's movement especially indicates to me that we're finally getting the traditional share price increase high quality medical advances usually get in the months leading up to a major regulatory decision. I think we're going to get to $.50 - $1.00 over the coming weeks and all eyes will turn to the MHRA for the announcement of their rulemaking on virtual controls.